Isabell Ricklefs

1.2k total citations
16 papers, 408 citations indexed

About

Isabell Ricklefs is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Immunology. According to data from OpenAlex, Isabell Ricklefs has authored 16 papers receiving a total of 408 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 5 papers in Physiology and 3 papers in Immunology. Recurrent topics in Isabell Ricklefs's work include Neonatal Respiratory Health Research (10 papers), Asthma and respiratory diseases (5 papers) and Cystic Fibrosis Research Advances (4 papers). Isabell Ricklefs is often cited by papers focused on Neonatal Respiratory Health Research (10 papers), Asthma and respiratory diseases (5 papers) and Cystic Fibrosis Research Advances (4 papers). Isabell Ricklefs collaborates with scholars based in Germany, Switzerland and Australia. Isabell Ricklefs's co-authors include Matthias Kopp, Sandra Barth, Mirjam Stahl, Marcus Mall, Christian Dopfer, Eva Tolosa, Anne Rissiek, Mark O. Wielpütz, Lutz Nährlich and Simon Y. Graeber and has published in prestigious journals such as Nature Communications, PLoS ONE and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Isabell Ricklefs

15 papers receiving 404 citations

Peers

Isabell Ricklefs
Shreyans Gandhi United Kingdom
Lori Singer United States
Timothy J. Vece United States
Madhura Pradhan United States
Isabell Ricklefs
Citations per year, relative to Isabell Ricklefs Isabell Ricklefs (= 1×) peers Tatsunori Jo

Countries citing papers authored by Isabell Ricklefs

Since Specialization
Citations

This map shows the geographic impact of Isabell Ricklefs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isabell Ricklefs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isabell Ricklefs more than expected).

Fields of papers citing papers by Isabell Ricklefs

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isabell Ricklefs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isabell Ricklefs. The network helps show where Isabell Ricklefs may publish in the future.

Co-authorship network of co-authors of Isabell Ricklefs

This figure shows the co-authorship network connecting the top 25 collaborators of Isabell Ricklefs. A scholar is included among the top collaborators of Isabell Ricklefs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Isabell Ricklefs. Isabell Ricklefs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Stichtenoth, Guido, Michael Zemlin, Isabell Ricklefs, et al.. (2025). Influenza Immunization in Very-Low-Birth-Weight Infants: Epidemiology and Long-Term Outcomes. Vaccines. 13(1). 42–42. 1 indexed citations
2.
Fortmann, Mats Ingmar, Alexander Humberg, Kirstin Faust, et al.. (2023). Respiratory Syncytial Virus Prophylaxis With Palivizumab Is Not Associated With Improved Lung Function in Infants of Very Low Birth Weight at Early School Age. 2(1). 100026–100026. 1 indexed citations
3.
Sommerburg, Olaf, Simon Y. Graeber, Cornelia Joachim, et al.. (2023). TRACK-CF prospective cohort study: Understanding early cystic fibrosis lung disease. Frontiers in Medicine. 9. 1034290–1034290. 2 indexed citations
4.
Rausch, Tanja K., Guido Stichtenoth, Isabell Ricklefs, et al.. (2023). Lung Function of Preterm Children Parsed by a Polygenic Risk Score for Adult COPD. NEJM Evidence. 2(3). EVIDoa2200279–EVIDoa2200279. 11 indexed citations
5.
Ricklefs, Isabell, Katrin Mehler, Wolfgang Göpel, et al.. (2022). Intratracheal treatment of surfactant plus topical steroids in very low birth weight (VLBW) infants following premature rupture of the membranes. Klinische Pädiatrie. 234(5). 347–348.
6.
Skevaki, Chrysanthi, Nina Timmesfeld, Markus Weckmann, et al.. (2021). Allergen extract‐ and component‐based diagnostics in children of the ALLIANCE asthma cohort. Clinical & Experimental Allergy. 51(10). 1331–1345. 7 indexed citations
7.
Winzer, Riekje, Anne Rissiek, Isabell Ricklefs, et al.. (2021). CD73-mediated adenosine production by CD8 T cell-derived extracellular vesicles constitutes an intrinsic mechanism of immune suppression. Nature Communications. 12(1). 5911–5911. 98 indexed citations
8.
9.
Weckmann, Markus, Inke R. König, André Franke, et al.. (2018). Rhinovirus infections change DNA methylation and mRNA expression in children with asthma. PLoS ONE. 13(11). e0205275–e0205275. 41 indexed citations
10.
Stahl, Mirjam, Mark O. Wielpütz, Isabell Ricklefs, et al.. (2018). Preventive Inhalation of Hypertonic Saline in Infants with Cystic Fibrosis (PRESIS). A Randomized, Double-Blind, Controlled Study. American Journal of Respiratory and Critical Care Medicine. 199(10). 1238–1248. 75 indexed citations
11.
Wielpütz, Mark O., Oyunbileg von Stackelberg, Mirjam Stahl, et al.. (2018). Multicentre standardisation of chest MRI as radiation-free outcome measure of lung disease in young children with cystic fibrosis. Journal of Cystic Fibrosis. 17(4). 518–527. 65 indexed citations
12.
Fuchs, Oliver, Thomas Bahmer, Markus Weckmann, et al.. (2018). The all age asthma cohort (ALLIANCE) - from early beginnings to chronic disease: a longitudinal cohort study. BMC Pulmonary Medicine. 18(1). 140–140. 28 indexed citations
13.
Raczkowski, Friederike, Anne Rissiek, Isabell Ricklefs, et al.. (2018). CD39 is upregulated during activation of mouse and human T cells and attenuates the immune response to Listeria monocytogenes. PLoS ONE. 13(5). e0197151–e0197151. 45 indexed citations
14.
Stahl, Matthias, Isabell Ricklefs, Christian Dopfer, et al.. (2018). WS14.3 Randomised, double-blind, controlled pilot study on safety and efficacy of hypertonic saline as preventive inhalation therapy in infants with CF (PRESIS). Journal of Cystic Fibrosis. 17. S25–S26. 3 indexed citations
15.
Stahl, Mirjam, Isabell Ricklefs, Simon Y. Graeber, et al.. (2018). Randomized, double-blind, controlled trial of preventive inhalation of hypertonic saline in infants with CF (PRESIS). OA513–OA513. 1 indexed citations
16.
Stahl, Mirjam, Simon Y. Graeber, Cornelia Joachim, et al.. (2017). Three-center feasibility of lung clearance index in infants and preschool children with cystic fibrosis and other lung diseases. Journal of Cystic Fibrosis. 17(2). 249–255. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026